- Home
- ALEC vs GENC Comparison
ALEC vs GENC Comparison
Compare ALEC & GENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALEC | GENC |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 262.7M | 232.2M |
| IPO Year | 2019 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ALEC | GENC |
|---|---|---|
| Price | $2.00 | $14.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $4.83 | ★ $17.60 |
| AVG Volume (30 Days) | ★ 718.7K | 27.4K |
| Earning Date | 05-07-2026 | 02-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8.08 |
| EPS | N/A | ★ 0.23 |
| Revenue | $21,045,000.00 | ★ $48,943,000.00 |
| Revenue This Year | $18.36 | $6.36 |
| Revenue Next Year | N/A | $8.32 |
| P/E Ratio | ★ N/A | $63.91 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.87 | $10.80 |
| 52 Week High | $3.40 | $17.40 |
Technical Indicators
Market Signals| Indicator | ALEC | GENC |
|---|---|---|
| Relative Strength Index (RSI) | 44.64 | 43.88 |
| Support Level | $1.87 | $13.59 |
| Resistance Level | $2.02 | $14.59 |
| Average True Range (ATR) | 0.14 | 0.57 |
| MACD | -0.03 | -0.06 |
| Stochastic Oscillator | 7.38 | 38.41 |
Price Performance
Historical ComparisonAbout ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
About GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries are a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company's products are manufactured in the United States and sold through a combination of Company sales representatives and independent dealers and agents. The Company has one reporting segment, equipment for the highway construction industry. The Company's principal core products include asphalt pavers, hot mix asphalt plants, combustion systems, and fluid heat transfer systems. It operates in the United States, Canada, and other foreign countries, with the majority of revenue coming from the United States.